Bifunctional complement inhibitor Therapy(BioCryst Pharmaceuticals)

N/A

Report date: 2023/12/18 14:02:18

Base Information

Drug NameBifunctional complement inhibitor Therapy(BioCryst Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLupus NephritisGlomerulonephritis, IGA
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiocryst Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiocryst Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsLupus NephritisGlomerulonephritis, IGA
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A